{"id":"https://openalex.org/W170296414","doi":null,"title":"Silymarin as a potential hypocholesterolaemic drug.","display_name":"Silymarin as a potential hypocholesterolaemic drug.","publication_year":1998,"publication_date":"1998-01-01","ids":{"openalex":"https://openalex.org/W170296414","mag":"170296414","pmid":"https://pubmed.ncbi.nlm.nih.gov/9708694"},"language":"en","primary_location":{"id":"pmid:9708694","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9708694","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Physiological research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077270649","display_name":"Nina \u0160kottov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I70703428","display_name":"Palack\u00fd University Olomouc","ror":"https://ror.org/04qxnmv42","country_code":"CZ","type":"education","lineage":["https://openalex.org/I70703428"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"N Skottov\u00e1","raw_affiliation_strings":["Institute of Medical Chemistry, Medical Faculty, Palack\u00fd University, Olomouc, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Medical Chemistry, Medical Faculty, Palack\u00fd University, Olomouc, Czech Republic","institution_ids":["https://openalex.org/I70703428"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085946928","display_name":"V Krecman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V Krecman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.4839,"has_fulltext":false,"cited_by_count":111,"citation_normalized_percentile":{"value":0.82643149,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"47","issue":"1","first_page":"1","last_page":"7"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12689","display_name":"Silymarin and Mushroom Poisoning","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12689","display_name":"Silymarin and Mushroom Poisoning","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13828","display_name":"Natural Products and Biological Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/silymarin","display_name":"silymarin","score":1.0},{"id":"https://openalex.org/keywords/milk-thistle","display_name":"Silybum marianum","score":0.9160000085830688},{"id":"https://openalex.org/keywords/flavonolignans","display_name":"flavonolignans","score":0.8799999952316284},{"id":"https://openalex.org/keywords/hypocholesterolaemic-effect","display_name":"hypocholesterolaemic effect","score":0.8759999871253967},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.9449999928474426},{"id":"https://openalex.org/keywords/dyslipoproteinemia","display_name":"dyslipoproteinemia","score":0.9190000295639038},{"id":"https://openalex.org/keywords/hepatic-lipid-metabolism","display_name":"hepatic lipid metabolism","score":0.7210000157356262},{"id":"https://openalex.org/keywords/plasma-lipoproteins","display_name":"serum lipoproteins","score":0.9350000023841858},{"id":"https://openalex.org/keywords/cholesterol-synthesis-inhibition","display_name":"cholesterol synthesis inhibition","score":0.8809999823570251},{"id":"https://openalex.org/keywords/hepatoprotective-effect","display_name":"hepatoprotection","score":0.8740000128746033},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.6890000104904175},{"id":"https://openalex.org/keywords/liver-injury","display_name":"liver injury","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C2780210117","wikidata":"https://www.wikidata.org/wiki/Q193798","display_name":"Silybum marianum","level":2,"score":0.9655129909515381},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6313573122024536},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6065748929977417},{"id":"https://openalex.org/C4733338","wikidata":"https://www.wikidata.org/wiki/Q2792936","display_name":"Lipid metabolism","level":2,"score":0.5610941052436829},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.5591459274291992},{"id":"https://openalex.org/C89311334","wikidata":"https://www.wikidata.org/wiki/Q1124842","display_name":"Drug metabolism","level":3,"score":0.5347543954849243},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.5218173861503601},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.48490744829177856},{"id":"https://openalex.org/C2776637226","wikidata":"https://www.wikidata.org/wiki/Q6658207","display_name":"Liver injury","level":2,"score":0.4745020568370819},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3423245847225189},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3412106931209564},{"id":"https://openalex.org/C556039675","wikidata":"https://www.wikidata.org/wiki/Q771035","display_name":"Traditional medicine","level":1,"score":0.2086745798587799}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008074","descriptor_name":"Lipoproteins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008074","descriptor_name":"Lipoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D010544","descriptor_name":"Peroxidases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D012838","descriptor_name":"Silymarin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D012838","descriptor_name":"Silymarin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D050356","descriptor_name":"Lipid Metabolism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9708694","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9708694","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Physiological research","raw_type":"Journal Article"},{"id":"mag:170296414","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9708694","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1979069013","https://openalex.org/W1986452732","https://openalex.org/W7006181044","https://openalex.org/W1986846545","https://openalex.org/W4235279226","https://openalex.org/W2921427583","https://openalex.org/W7095495285","https://openalex.org/W2143894406","https://openalex.org/W2335876230","https://openalex.org/W3107686303"],"abstract_inverted_index":{"Silymarin,":[0],"a":[1,57,111,132],"mixture":[2],"of":[3,15,18,45,47,66,83,88,100],"flavonolignans":[4],"from":[5],"medicinal":[6],"plant":[7],"Silybum":[8],"marianum,":[9],"is":[10,27,53,123],"used":[11],"in":[12,43],"supportive":[13],"treatment":[14],"liver":[16,38,51,84,93,115],"diseases":[17],"different":[19],"etiology":[20],"due":[21],"to":[22,29,63,92,97,128],"its":[23],"hepatoprotective":[24],"activity,":[25],"which":[26,60],"considered":[28],"involve":[30],"antioxidative":[31],"and":[32,50],"the":[33,64,76,98],"membrane":[34],"stabilizing":[35],"effects.":[36],"The":[37],"plays":[39],"an":[40],"important":[41],"role":[42],"regulation":[44,99],"metabolism":[46,95,117],"plasma":[48,101],"lipoproteins,":[49],"injury":[52],"often":[54],"reflected":[55],"as":[56,131],"secondary":[58],"dyslipoproteinaemia,":[59],"may":[61,86],"lead":[62],"development":[65],"atherosclerosis,":[67],"particularly":[68],"when":[69],"associated":[70],"with":[71,90],"hypercholesterolaemia.":[72],"This":[73],"review":[74],"summarizes":[75],"experimental":[77],"evidence":[78],"indicating":[79],"that":[80,107,125],"silymarin-induced":[81],"protection":[82],"functions":[85],"be":[87,129],"benefit":[89],"regard":[91],"lipid":[94],"related":[96],"lipoproteins.":[102],"Moreover,":[103],"some":[104],"data":[105],"suggest":[106],"silymarin":[108,126],"could":[109],"have":[110],"direct":[112],"effect":[113],"on":[114],"cholesterol":[116,120],"by":[118],"inhibiting":[119],"biosynthesis.":[121],"It":[122],"proposed":[124],"deserves":[127],"studied":[130],"potential":[133],"hypocholesterolaemic":[134],"agent.":[135]},"counts_by_year":[{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}